I agree that this site is using cookies. You can find further informations here.
X
Paschke, Amanda
48  results:
Search for persons X
?
1

Correction to: Virologic Outcomes with Molnupiravir in Nonh..:

Strizki, Julie M. ; Grobler, Jay A. ; Murgolo, Nicholas...
Infectious Diseases and Therapy.  13 (2024)  5 - p. 1159-1160 , 2024
Link: https://doi.org/10.1007/..
 
?
2

Respiratory virus coinfections during the COVID-19 pandemic..:

Johnson, Matthew G. ; Strizki, Julie M. ; Jensen, Erin...
Microbiology Spectrum.  12 (2024)  3 - p. , 2024
Link: https://doi.org/10.1128/..
 
?
3

Factors Influencing COVID‐19 Risk: Insights From Molnupirav..:

Chawla, Akshita ; Birger, Ruthie ; Wan, Hong...
Clinical Pharmacology & Therapeutics.  113 (2023)  6 - p. 1337-1345 , 2023
Link: https://doi.org/10.1002/..
 
?
4

Imipenem/cilastatin/relebactam efficacy, safety and probabi..:

Roberts, Jason A ; Nicolau, David P ; Martin-Loeches, Ignacio...
JAC-Antimicrobial Resistance.  5 (2023)  2 - p. , 2023
Link: https://doi.org/10.1093/..
 
?
5

Virologic Outcomes with Molnupiravir in Non-hospitalized Ad..:

Strizki, Julie M. ; Grobler, Jay A. ; Murgolo, Nicholas...
Infectious Diseases and Therapy.  12 (2023)  12 - p. 2725-2743 , 2023
Link: https://doi.org/10.1007/..
 
?
6

Pharmacokinetics, Safety, and Tolerability of Imipenem/Cila..:

Bradley, John S. ; Makieieva, Nataliia ; Tøndel, Camilla...
The Journal of Clinical Pharmacology.  63 (2023)  12 - p. 1387-1397 , 2023
Link: https://doi.org/10.1002/..
 
?
7

Molnupiravir for intra-household prevention of COVID-19: Th..:

Alpizar, Sady A. ; Accini, Jose ; Anderson, Duane C....
Journal of Infection.  87 (2023)  5 - p. 392-402 , 2023
Link: https://doi.org/10.1016/..
 
?
8

Impact of Molnupiravir Treatment on Patient-Reported COVID-..:

Guan, Yanfen ; Puenpatom, Amy ; Johnson, Matthew G...
Clinical Infectious Diseases.  77 (2023)  11 - p. 1521-1530 , 2023
Link: https://doi.org/10.1093/..
 
?
9

Molnupiravir for the treatment of COVID-19 in immunocomprom..:

Johnson, Matthew G. ; Strizki, Julie M. ; Brown, Michelle L....
Infection.  51 (2023)  5 - p. 1273-1284 , 2023
Link: https://doi.org/10.1007/..
 
?
10

Participant- and Disease-Related Factors as Independent Pre..:

Martin-Loeches, Ignacio ; Shorr, Andrew F ; Kollef, Marin H...
Open Forum Infectious Diseases.  10 (2023)  6 - p. , 2023
Link: https://doi.org/10.1093/..
 
?
11

Population pharmacokinetics of molnupiravir in adults with ..:

Bihorel, Sébastien ; Cao, Youfang ; Chawla, Akshita...
CPT: Pharmacometrics & Systems Pharmacology.  12 (2023)  12 - p. 1859-1871 , 2023
Link: https://doi.org/10.1002/..
 
?
12

1159. Pharmacokinetics, Safety, and Tolerability of Imipene..:

Bradley, John S ; Makieieva, Nataliia ; Tøndel, Camilla...
Open Forum Infectious Diseases.  8 (2021)  Supplement_1 - p. S671-S671 , 2021
Link: https://doi.org/10.1093/..
 
?
13

The safety and efficacy of relebactam/imipenem/cilastatin i..:

Kohno, Shigeru ; Bando, Hiroyuki ; Yoneyama, Fumihiko...
Journal of Infection and Chemotherapy.  27 (2021)  2 - p. 262-270 , 2021
Link: https://doi.org/10.1016/..
 
?
14

1574. Multivariate Regression Analysis to Determine Indepen..:

Tipping, Robert ; Du, Jiejun ; Losada, Maria C...
Open Forum Infectious Diseases.  7 (2020)  Supplement_1 - p. S785-S786 , 2020
Link: https://doi.org/10.1093/..
 
?
15

A Randomized, Double-blind, Multicenter Trial Comparing Eff..:

Titov, Ivan ; Wunderink, Richard G ; Roquilly, Antoine...
Clinical Infectious Diseases.  73 (2020)  11 - p. e4539-e4548 , 2020
Link: https://doi.org/10.1093/..
 
1-15